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Biomarkers of post-discharge 
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emily Nyatichi1,2, Johnstone thitiri1,2, Gerard Bryan Gonzales3,8, Robert H. J. Bandsma1,7, 
Judd L. Walson1,6, Evelyn N. Gitau  4 & James A. Berkley  1,2,5
High mortality after discharge from hospital following acute illness has been observed among children 
with Severe Acute Malnutrition (SAM). However, mechanisms that may be amenable to intervention 
to reduce risk are unknown. We performed a nested case-control study among HIV-uninfected children 
aged 2–59 months treated for complicated SAM according to WHO recommendations at four Kenyan 
hospitals. Blood was drawn from 1778 children when clinically judged stable before discharge from 
hospital. Cases were children who died within 60 days. Controls were randomly selected children 
who survived for one year without readmission to hospital. Untargeted proteomics, total protein, 
cytokines and chemokines, and leptin were assayed in plasma and corresponding biological processes 
determined. Among 121 cases and 120 controls, increased levels of calprotectin, von Willebrand factor, 
angiotensinogen, IL8, IL15, IP10, TNFα, and decreased levels of leptin, heparin cofactor 2, and serum 
paraoxonase were associated with mortality after adjusting for possible confounders. Acute phase 
responses, cellular responses to lipopolysaccharide, neutrophil responses to bacteria, and endothelial 
responses were enriched among cases. Among apparently clinically stable children with SAM, a 
sepsis-like profile is associated with subsequent death. This may be due to ongoing bacterial infection, 
translocated bacterial products or deranged immune response during nutritional recovery.
Malnutrition is an underlying cause of nearly half of global deaths in children below 5 years mainly in sub-Saharan 
Africa and Asia1,2. Evidence suggests that most deaths are due to common infectious diseases, mainly pneumonia, 
diarrhoea, and malaria; and lower nutritional status is associated with markedly increased risk of mortality across 
these syndromes1–7. Children with severe acute malnutrition (SAM) are treated according to standardized World 
Health Organization (WHO) guidelines using antibiotics, correction of nutritional deficiencies through thera-
peutic feeding, and treatment of other medical conditions8. Children with complicated SAM defined as those 
with infections, severe oedema, failing an appetite test, or presenting with one or more Integrated Management 
of Childhood Illness (IMCI) danger signs are initially treated as inpatients before being discharged to outpatient 
therapeutic feeding care once stabilized8. Complicated SAM is typically associated with an in-patient mortality 
risk of 12% to more than 30% in African hospitals9–12.
A high rate of mortality in the months following hospital discharge has been observed among children with 
SAM in sub-Saharan Africa13–22. A recent systematic review reported paediatric post-discharge mortality rates 
in resource-poor countries of up to 18% which may exceed in-hospital mortality rates in many settings18,23. 
This implies that processes underlying susceptibility to mortality continue beyond the clinically evident acute 
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episode. In these studies, poor nutritional status, young age, and HIV were all associated with higher mortality 
risk post-discharge. However, while anthropometry and clinical parameters are important in selection of chil-
dren requiring specialized care and monitoring, they are non-specific and do not indicate specific mechanisms 
that may lead to death. Whilst mechanisms resulting in post-discharge deaths are not well understood, they are 
likely to involve the interaction between the metabolic consequences of malnutrition, infection, and intestinal 
dysfunction, whose causes and consequences are “cyclic” and self-reinforcing7,24. This sustained risk of death 
post-discharge following apparent medical stabilization calls for an understanding of processes that could be 
amenable to intervention.
The objective of this study was to characterize the plasma proteomic profile associated with early 
post-discharge mortality in children who were medically treated for complicated SAM and nutritionally stabi-
lized. We hypothesized that early post-discharge mortality in children with SAM is associated with derangements 
in certain biological processes that could be ascertained by measuring plasma proteins measured before discharge 
from the hospital. Specifically, we hypothesized that an increased inflammatory response is associated with mor-
tality. Hence, we used both untargeted (plasma protein profiles) and targeted (cytokines, chemokines, and leptin) 
approaches to determine associations with mortality within the next 60 days among children who had been 
judged medically stabilized according to WHO guidelines.
Results
Characteristics of study children, clinical causes of mortality, and full blood count. The baseline 
characteristics of the study children measured at discharge are given in Table 1. Children (n = 241) in this nested 
case-control study had mean MUAC of 10.4 (SD ± 1.2) and 41 (18%) had nutritional oedema. Post-discharge 
deaths occurred a median of 19 (Interquartile range, IQR 7–34) days after sampling, mostly (60%) during read-
mission to the study hospitals, while the rest were in the community (31%) and other hospitals (8%) (Table 2). 
Pneumonia, sepsis, diarrhoea, and febrile illness were the commonest clinical syndromes recorded as causing 
death. Blood culture was performed for those readmitted to study hospitals, but few were positive (Table 2). 
Among the four blood culture isolates identified, only one was likely to be sensitive to one of the recommended 
first line antibiotics for use in hospital (penicillin or ampicillin plus gentamicin) (Table S3).
Compared to controls, cases were younger (P = 0.02) representing a greater percentage of those below 
6 months (28% vs 11%, P = 0.001). Cases also had significantly lower MUAC (P < 0.001) and weight-for-age 
Z-score (WAZ) compared to controls (P = 0.01). Lower platelet counts and higher neutrophil counts were found 
in cases compared to controls on univariate analysis, however, these were not significant when adjusted for age, 
site and randomization arm.
Cases are characterized by low total plasma protein. The plasma total protein is predominantly com-
prised of albumin and immunoglobulins (reference ranges between 60–80 mg/ml25–27). Cases had significantly 
lower total plasma protein concentration (median; 59.9 mg/ml, IQR; 51.4–70) compared to controls (median; 
67.3 mg/ml, IQR 60.1–74.8) (P < 0.001, Fig. 1, Table S4). The median total plasma protein among controls was 
well within the normal reference range and just below the lower threshold of the reference range for cases.
Systemic inflammatory proteins are increased among cases. We compared expression levels of 
quantified specific proteins between cases and controls. Our untargeted liquid chromatography-tandem mass 
spectrometry based proteomics analysis resulted in the relative quantification of 444 proteins after excluding 
potential contaminants and identifications from the decoy database. A decoy FASTA database is generated 
from the target database, comprising sequences derived from the organism being studied, by switching the 
amino-carboxyl orientation of a protein’s amino acids to generate sequences that do not exist in nature, which 
are then concatenated with the target FASTA database28. Of the quantified proteins, 146 (33%) were quanti-
fied in all the study children. Twelve proteins were found to be differentially expressed (FDR ≤ 0.05; Fig. 2, 
Table S5). C-reactive protein, subunits of calprotectin (Protein S100-A8/S100-A9), plastin-2, angiotensinogen, 
and lipopolysaccharide-binding protein (LBP) were higher among cases, while heparin cofactor 2 and serum 
paraoxonase/arylesterase 1 proteins were higher among controls (Fig. 2A, Table S5).
Among the cytokines and chemokines assayed (n = 29); IL8, IL15, G-CSF, IP10, and TNFα were significantly 
higher among cases (FDR ≤ 0.05; Fig. 2B, Table S6). However, sCD14 was not significantly different between the 
cases and controls (P = 0.09, Table S4).
In pairwise correlation analysis, most inflammatory proteins were positively correlated with each other and 
with VWF (Fig. 3). Further, SERPIND1 and PON1, both of which were lower among cases, were negatively asso-
ciated with CRP and inflammatory cytokines (Fig. 3).
Unsupervised clustering analysis using concatenated proteome and cytokine measurements and visualized 
using principal component analysis (PCA) did not reveal any case-control group separation or clustering (data 
not shown).
Cases are characterized by hypoleptinemia. Leptin was significantly lower among cases (P = 0.001, 
Fig. 4A-panel Leptin, Table S4). Hypoleptinemia has been previously described as a predictor of mortality in 
children undergoing treatment for SAM and a leptin cut-off of <35 pg/ml was suggested29. A leptin value of 
<35 pg/ml (n = 13) in the current study also had a high predictive value P < 0.0001 (Fig. 4B, data not shown in 
tables). Additionally, among cases, the median time to death for those with low leptin (<35 pg/ml) was shorter (9 
days, IQR; 4.5–16.5) than among those with higher levels (20 days, IQR; 7–38: P = 0.04, data not shown in tables). 
In further analysis, leptin was negatively correlated with inflammatory proteins, von Willebrand factor (VWF) 
(Fig. 3) and with lower MUAC (P < 0.0001; Fig. 3).
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GO term enrichment analysis indicates acute inflammatory response to bacteria. Biological 
process enrichment analysis for proteins upregulated among cases showed enrichment of several Gene Ontology 
(GO) terms (Fig. 5). These include “inflammatory response”, “cellular response to lipopolysaccharide”, “immune 
response”, “acute phase response”, “defence response to gram-positive bacteria”, and “positive regulation of nuclear 
factor-kappa B transcription factor activity” among others (Fig. 5).
Proteins involved in inflammation and endothelial function are associated with death. We 
examined the association between individual proteins and mortality by adjusting for putative confounders using 
multivariate Cox proportional regression, including a term for changes in effect over time (see methods, Table 3). 
Increased levels of inflammatory proteins including calprotectin, IL8, IL15, IP10, and TNFα were associated with 
death (Table 3). Elevated plasma levels of VWF and low levels of PON1 and SERPIND1 were also associated with 
mortality (All P < 0.01, Table 3). However, several proteins including CRP, LCP1, Β2M, and G-CSF, that appeared 
differentially expressed in univariate analysis, were not associated with mortality after adjusting for confounders 
(See Table 3). A declining effect over time was observed for VWF and inflammatory proteins, IL8 and TNFA, 
thus children with the highest values died earlier (Table 3; Fig. S1). The effect of age was also noted to interact 
with time in these models, with the youngest children having higher late mortality risk (all P < 0.01), illustrated 
in Fig. S1.
Plasma leptin was associated with death after adjusting for confounders (P = 0.009, Table 3), without evidence 
of change in effect over time (P = 0.1, Table 3). Total plasma protein was not associated with mortality (P = 0.35, 
Table 3).
Discussion
This study sought to identify biomarkers that suggest biological processes involved in early post-discharge death 
and that might provide insights into interventional targets to reduce mortality among a group of children at high 
risk of death. This study focused on early post-discharge mortality (<60 days) because this is the period with the 
highest mortality rate and is more likely to be related to factors measurable at discharge than later deaths13,16,18,19.
Our results show that children who subsequently died had evidence of elevated inflammatory, acute phase, 
endothelial, and innate cellular responses suggesting exposure to circulating bacteria or bacterial products at a 
time when they were clinically judged to be stable. Systemic inflammation markers including calprotectin, CRP, 
and cytokines: G-CSF, IL8, IL15, IP10, and TNFα were increased among cases. Several of these inflammatory 





(N = 120) P Padj
       Gender (female) – No. (%) 59 (49) 53 (44) 0.48 —
       Age (months) – median (IQR) 9 (5–14) 11.5 (7–16) 0.02 —
       Under six months) – No. (%) 34 (28) 13 (11) 0.001 —
Recruitment site
       Kilifi – no. (%) 5 (4.1) 6 (5.0) 0.98 —
       Mombasa – no. (%) 64 (53) 64 (53)
       Malindi – no. (%) 23 (19) 23 (19)
       Mbagathi – no. (%) 29 (24) 27 (23)
Clinical Variables
       Nutritional oedema – no. (%) 20 (17) 21 (18) 0.84 0.84
       Mid upper arm circumference – cm ± sd 10.1 ± 1.2 10.8 ± 1.1 <0.001 0.005
       Length-for-age z score ± sd −3.0 ± 2.0 −2.9 ± 1.7 0.78 0.84
Diagnosis at index admission
       Severe pneumonia – no. (%) 49 (41) 40 (33) 0.25 0.86
       Diarrhoea – no. (%) 68 (56) 66 (55) 0.85 0.99
       Shock – no. (%) 12 (9.9) 12 (10) 0.98 0.99
       Clinical signs of rickets — no. (%) 24 (20) 12 (10) 0.03 0.21
       Known tuberculosis – no. (%) 7 (5.8) 7 (5.8) 0.99 0.99
       Cerebral palsy – no. (%) 4 (3.3) 4 (3.3) 0.99 0.99
       Randomized to co-trimoxazole prophylaxis – no. (%) 60 (50) 60 (50) 0.95 0.99
Full blood count
       Haemoglobin g/dl ± sd 9.6 ± 2.1 9.8 ± 1.9 0.43 0.57
       Platelets counts (×103/L) – median (IQR) 387 (203–531) 474 (280–583) 0.02 0.1
       WBC counts (×103/L) – median (IQR) 10.5 (7.9–14.8) 9.3 (6.5–12.8) 0.06 0.1
       Lymphocytes counts (×103/L) – median (IQR) 4.7 (3–7.0) 4.9 (2.9–6.7) 0.90 0.9
       Neutrophils counts (×103/L) – median (IQR) 3.5 (2.2–5.9) 3.0 (1.9–4.5) 0.05 0.1
Table 1. Baseline characteristics of the study participants. IQR = interquartile range, sd = Standard deviation, 
no = number, Padj = P value corrected for false discovery.




    Mortality involving first SAE – no. (%) 111 (92)
    Mortality involving second SAE – no. (%) 10 (8)
Location of death
    Study hospital – no. (%) 73 (60)
    Community – no. (%) 30 (31)
    Other hospital – no. (%) 10 (8)
Time to death
    Days – median (IQR) 19 (7–34)
Clinically assigned cause of death*
    Pneumonia – no. 42
    Sepsis – no. 30
    Gastroenteritis – no. 29
    Unknown (no cause assigned) – no. 24
    Unknown febrile illness – no. 17
    Encephalopathy of unknown cause – no. 6
    Pulmonary TB – no. 2
    Malaria – no. 2
Bacterial pathogens detected in blood
    Klebsiella pneumoniae – no. 1
    Pseudomonas aeruginosa – no. 1
    Non-typhoidal Salmonella sp. – no. 1
    Streptococcus pneumoniae – no. 1
Table 2. Details of mortality and clinical causes among cases. SAE = severe adverse event, *More than one 
cause may be present in individuals. no. = number.
Figure 1. Plasma total protein concentration is significantly different between cases (n = 119) and controls 
(n = 119). Box plot summarize the median and interquartile ranges of plasma total protein and P values < 0.05 
are significant.
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related to systemic inflammation. Overall, our data is consistent with other studies showing that during infection, 
undernourished children have increased positive acute phase proteins (CRP, α1-acid glycoprotein, haptoglo-
bin), IL4, IL6, and IL10 and reductions in IL2, and IFNγ compared to well-nourished children30. In addition to 
heightened inflammation, children with complicated SAM are often characterized by deranged metabolism. For 
example, the levels of amino acids, plasma protein, non-esterified fatty acids, hormones including leptin, were 
significantly altered at admission in a Ugandan cohort of children with complicated SAM29. Bartz et al. showed 
that inpatient mortality was associated with low levels of high molecular weight adiponectin, hypoleptinemia, as 
Figure 2. Systemic inflammatory proteins are increased among cases. (A) Bar plot of differentially expressed 
proteins from the mass spectrometry-based proteome analysis between cases (n = 121) and controls (n = 120). 
The analysis was performed using proteome measurements in plasma among cases and controls. The bar graph 
depicts the log10 of the fold change of differentially expressed proteins. Red and green bars indicate significantly 
up- and downregulated proteins among cases. (B) Box plot summaries of the median and interquartile ranges 
of natural logarithm concentrations of 5 cytokines that were significantly different between cases (n = 112) and 
controls (n = 113). Overlaid dots represent individual data points. GCSF, granulocyte-colony stimulating factor; 
IL8, interleukin 8; IL15, interleukin 15; IP10, Interferon gamma-induced protein 10 (IP-10)/chemokine (C-X-C 
motif) ligand 10; TNFA, tumour necrosis factor; P values represent the adjusted P value using the Benjamini 
and Hochberg (BH) method for multiple testing.
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Figure 3. Pairwise correlation heatmap among differentially expressed proteins FDR < 0.05, MUAC, age, 
Protein, and leptin. MUAC, Mid upper arm circumference. Protein, Total plasma protein. 1 and −1 depicts the 
highest positive and negative correlation values respectively in the correlation matrix. Pairwise correlations 
highlighted in bold are P < 0.05 and those with bold and underlined are P < 0.001.
Figure 4. Leptin concentrations are significantly different between cases (n = 119) and controls (n = 119). 
(A) Box plot summary of the median and IQRs of natural logarithms of leptin concentrations. Overlaid dots 
represent individual data points. (B) Leptin concentration, showing only those <100 pg/ml among cases and 
controls. The dot plot depicts the 35 pg/ml leptin cut-off and dots represent the individual leptin data points 
<100 pg/ml. P < 0.05 are significant.
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well as high levels of peptide YY and several inflammatory cytokines29. Such elevated inflammation and deranged 
metabolism may partly explain why normal clinical manifestations of infection such as fever or respiratory dis-
tress may not be as apparent in children with SAM11,31.
Calprotectin is predominantly expressed by neutrophils, monocytes, and activated endothelial and epithelial 
cells and plays a role in the inflammatory response to LPS by inducing the release of neutrophils from the bone 
marrow and directing migration to the inflammatory site32. It is upregulated in humans and neonatal rats with 
sepsis33–35. Additionally, G-CSF, the principal factor that regulates the maturation, proliferation, and differenti-
ation of neutrophil precursors was elevated among cases but was not associated with mortality after adjusting 
Figure 5. Enrichment analysis of upregulated proteins among cases. Biological processes associated with 
early post-discharge mortality in children with SAM based on Gene Ontology (GO) analysis. The analysis for 
pathways enriched was performed using the DAVID Bioinformatics Resources version 6.8. The Bar graphs 
depict the enriched GO process category and the −log10 of the P value. The P value depicts the probability that 
a particular biological process is enriched in a group of proteins relative to other biological processes.
Measurement aHR [95% CI] P aHRtvc [95% CI]tvc Ptvc
CRP 1.32 0.96−1.81 0.087 1.00 0.99−1.01 0.821
S100A8 1.64 1.16−2.33 0.006 0.99 0.98−1.01 0.318
S100A9 1.81 1.21−2.70 0.004 0.99 0.97−1.00 0.105
LCP1 2.37 0.99−5.64 0.052 0.98 0.95−1.02 0.349
LBP 1.73 0.82−3.65 0.149 0.98 0.95−1.01 0.211
VWF 4.19 1.93−9.11 <0.001 0.95 0.93−0.98 0.002
Β2M 2.16 0.93−5.02 0.074 0.99 0.96−1.02 0.321
AGT 2.72 1.23−6.03 0.014 0.98 0.96−1.01 0.269
LRG1 1.21 0.53−2.75 0.646 1.00 0.97−1.03 0.864
SERPINA3 1.57 0.72−3.44 0.262 1.00 0.97−1.03 0.973
PON1 0.39 0.20−0.77 0.007 1.01 0.99−1.04 0.413
SERPIND1 0.38 0.21−0.70 0.002 1.00 0.97−1.03 0.866
GCSF 1.16 0.97−1.39 0.106 1.00 1.00−1.01 0.530
IL8 1.62 1.26−2.08 <0.001 0.99 0.98−1.00 0.016
IL15 1.31 1.05−1.63 0.015 1.00 0.99−1.00 0.149
IP10 1.61 1.16−2.23 0.004 0.98 0.99−1.00 0.203
TNFA 2.20 1.47−3.30 <0.001 0.98 0.97−0.99 0.002
Leptin 0.69 0.52−0.91 0.009 1.01 1.00−1.02 0.121
Total protein 0.48 0.11−2.21 0.348 0.96 0.90−1.02 0.166
Table 3. Multivariate Cox regression analysis between individual proteins and death. Multivariate analysis of 
log values of protein variables with FDR < 0.05, leptin, and total plasma protein. aHR, Hazard Ratio adjusted for 
age, sex, nutritional oedema, study site, baseline MUAC, and randomization arm. CI, Confidence Interval; tvc, 
time varying covariate to test the interaction of each protein covariate with time; HRtvc indicates change in HR 
per unit time (day). Total protein, total plasma protein.
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for nutritional status, age, sex, and other possible confounders. G-CSF also regulates production of TNFα36 and 
promotes the release of IL1Ra37. Further, LBP, CRP, and VWF which were observed to be higher among cases, 
have previously been reported to be elevated in sepsis38–40. Interferon-gamma (IFNγ)-inducible protein, IP10, an 
early mediator of the host response to sepsis41 was associated with mortality. IP10 is produced by endothelial cells, 
monocytes, fibroblasts, and keratinocytes in response to IFNγ and plays an important role in the effector T cell 
generation and recruitment to sites of inflammation42. Our results are consistent with a previous study showing 
elevated markers of systemic inflammation were significantly associated with inpatient mortality in SAM43 and 
extends those findings to the early post-discharge period. Taken together, these results suggest that among cases 
who died up to 60 days later, at the time of appearing stable, there was a sepsis-like immunopathogenic profile, 
likely arising from ongoing active infections that may have been only partially treated or resistant to the antibiot-
ics used, or from circulating translocated bacterial products from loss of intestinal barrier function44,45.
Further analysis focused on leptin, an adipose-derived hormone, that acts centrally in the hypothalamus to 
regulate food intake, body weight, and energy balance46,47. Leptin also plays a role in immune homeostasis by 
differentially regulating the proliferation of naive and memory T cells, enhances Th1 and suppresses Th2 cytokine 
production, and reverses starvation-induced immunosuppression48–50. Very low leptin concentration has pre-
viously been reported as a biomarker of mortality in hospitalized Ugandan children undergoing treatment for 
SAM, and leptin rapidly rises with recovery29. In the Ugandan cohort, Mody et al. showed that leptin levels were 
lower in HIV-infected than in non-infected SAM children at diagnosis and that both HIV, hypoleptinemia, and 
hypoadiponectinemia were associated with increased mortality51. Our data shows that leptin was associated with 
mortality and negatively correlated with inflammation and with lower MUAC which is consistent with findings 
from inflammatory diseases13,29,52. The cut-off of leptin <35 pg/ml suggested by Bartz et al., had high positive pre-
dictive value but low sensitivity for subsequent death in our study and children with low leptin levels died earlier. 
Higher overall leptin levels among cases in our study is likely to be because leptin measurements were conducted 
following medical stabilization and ability to complete therapeutic feeds, whilst the measurements by Bartz et al., 
were conducted before initiation of treatment29. It is worth noting that leptin levels are affected by food intake 
and metabolism, and could be a contributing mediator of the immunosuppressive state in undernutrition53–55.
We observed that beside inflammatory markers, higher levels of VWF and AGT were associated with death. 
VWF is a biomarker of endothelial activation and plays a major role in platelet adhesion and aggregation for hae-
mostasis, and connects haemostatic and inflammatory pathways, recruiting neutrophils and other leucocytes56–58. 
VWF is elevated in patients with inflammatory and metabolic conditions as well as in severe sepsis and septic 
shock59. Our data showed that several inflammatory markers were positively correlated with VWF and is therefore 
in agreement with previous studies that have demonstrated a link between systemic inflammation and endothelial 
activation60–62. AGT, the common precursor of all angiotensin peptides, is a component of the renin-angiotensin 
system (RAS), a hormone system that is pivotal to the regulation of blood pressure and homeostasis of water and 
sodium through actions of angiotensin II63. The elevated levels of AGT among children who died may point to 
fluid and electrolyte disturbances which are often observed in critically ill patients64. Taken together, these data 
may imply that the vascular system and hemodynamic processes in ill undernourished children are perturbed 
and might not have resolved following in-patient treatment, likely related to ongoing infection.
Further, low levels of PON1 and SERPIND1 were also associated with mortality. PON1 plays a number of roles 
including as an antioxidant and anti-inflammatory (through destruction of oxidised lipid), helps preserve High 
Density Lipoprotein function, stimulates cholesterol efflux, and acts as an anti-apoptosis, anti-thrombosis, and 
anti-adhesion agent65. Low levels of PON1 may lead to the dysregulation of the aforementioned processes that 
are critical for metabolism and general homeostasis thereby increasing risk of mortality in ill undernourished 
children. Overall, it is likely that inflammation, endothelial activation, and other related biological processes 
synergistically increase the risk of mortality among malnourished children.
This study was a secondary analysis of samples collected from a previous trial. We acknowledge that the results 
reported here are hypothesis generating and require validation within additional and larger independent cohorts. 
The sample size limited main effect estimates, and tests of interaction with time to identifying only larger effects. 
This study did not include HIV-infected children, whose mortality rates often exceed children without HIV infec-
tion. Mortality in HIV-infected children may be due to different underlying biological processes. Using both 
untargeted and targeted protein analyses, only a limited number of plasma proteins, cytokines, and chemokines 
were measured and potentially important proteins occurring at low abundances may have been missed. Cellular 
component ontology analysis of quantified proteins using DAVID66 indicated significant enrichment in proteins 
present in extracellular exosomes, extracellular space, extracellular region, blood microparticle, extracellular 
matrix, among others (data not shown) and therefore contamination with cellular material was likely minimal 
if present. We also did not actively measure nutritional factors, hormones, electrolytes, and metabolites which 
would have contributed further to the understanding of causal mechanisms to mortality. The limited sensitivity 
of bacterial culture as well as lack of investigation into viral and other infectious causes and deaths occurring in 
the community limited our ability to evaluate causes of death.
Conclusions
To our knowledge, this is the first study to evaluate biomarkers associated with subsequent mortality in children 
who appear to have been medically and nutritionally stabilized prior to discharge. Children who subsequently 
died were characterized by acute inflammatory and vascular response compatible with exposure to circulating 
bacteria or bacterial products, reduced antioxidant defence, together with low total plasma protein and hypolep-
tinemia. Our results suggest early post-discharge mortality is likely to result from ongoing partially-treated bac-
terial infections or hazardous intestinal bacterial translocation.
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Subjects and Methods
study design and patient recruitment. We conducted a nested case-control study using samples and 
clinical data obtained at enrolment from a randomized placebo-controlled trial investigating the efficacy of daily 
co-trimoxazole prophylaxis to prevent long-term mortality among HIV-uninfected children with complicated 
SAM19. Details of the trial protocol including participants inclusion and exclusion criteria have been published19. 
Briefly, the study was conducted in two urban (Mombasa and Nairobi) and two rural (Kilifi and Malindi) hos-
pitals in Kenya and recruited children aged 2 months to 5 years who had been treated and achieving clinical-
ly-judged stability according to WHO recommendations. Severe malnutrition was defined as: age 6 months to 
5 years; mid upper arm circumference (MUAC) <11.5 cm, age 2 to 6 months; MUAC <11 cm, or kwashiorkor 
at any age (defined in current WHO guidelines)19,67. Children were also HIV rapid test negative; or if under 18 
months, HIV-1 PCR negative and no longer breastfeeding for at least 6 weeks.
Children were recruited prior to discharge when they had completed the ‘stabilization’ phase of inpatient care, 
defined by WHO as not having WHO ‘danger’ or ‘emergency’ signs, improvement in oedema, if present, and able 
to complete prescribed feeds. Samples and clinical data were collected from study participants prior to initiation 
of the investigational product: co-trimoxazole or placebo.
For this study, cases (n = 121) were defined as children who died within 60 days while controls (n = 120) were 
randomly selected children who survived and were not readmitted to hospital during 1 year of follow up. From 
the original study population of 1778, 147 (8.3%) children died within the first 60 days. Cases and controls were 
included in this analysis if they had sufficient stored plasma sample for analysis. Differences between included 
and excluded cases were not statistically significant (Table S1).
ethics approval and consent to participate. The study had been reviewed and approved by Kenya 
Medical Research Institute (KEMRI) Scientific and Ethics Review Committee (SERU: No. 2782) and informed 
consent had been sought from mother’s or guardians of study participants. All experiments were conducted 
according to Good Clinical Laboratory Practice guidelines.
plasma proteomics. Individual plasma samples (10 μl) were depleted the top 12 abundant plasma proteins 
using spin columns (Thermo scientific) following manufacturer’s instructions. The volume of the flow through 
was reduced to ~50 μl and protein concentration determined using Bradford assay (Bio-Rad). Proteins samples 
(30 μg) were adjusted with 50 mM Triethylamonium bicarbonate (TEAB, Sigma-Aldrich) to 100 μl. The protein 
solution was then reduced with 40 mM tris(2-carboxyethyl)phosphine (TCEP, Sigma-Aldrich) at 55 °C for 1 hour 
and subsequently alkylated with 80 mM iodoacetamide (Sigma-Aldrich) for 1 hour protected from light at room 
temperature. Proteins were precipitated overnight at −20 °C with six volumes of pre-chilled (−20 °C) acetone 
(Sigma-Aldrich). The samples were then centrifuged at 8,000 g for 10 min at 4 °C and the supernatant discarded.
The acetone-precipitated protein pellet was resuspended in 100 µl of 50 mM TEAB. Trypsin (Sigma-Aldrich) 
was added to the protein samples at a trypsin-protein sample ratio of 1:15 and protein digestion was allowed to 
proceed overnight at 37 °C with shaking. A pooled sample was prepared by combining 1 μl aliquot from each 
sample. Peptide samples were individually labelled using the Tandem Mass Tag (TMT) 10-plex kit (Thermo sci-
entific) according to manufacturer’s instructions. Two isobaric tags were exclusively used to individually label two 
pooled control samples. The labelled peptides for the 8 individual tags in the 10-plex were subsequently combined 
to generate individual pools upon which the two common pools were equally distributed. The labelled peptide 
pools were desalted using P10 C18 pipette ZipTips (Millipore) according to manufacturer’s instructions. Eluted 
peptides were dried in a Speedvac concentrator (Thermo Scientific) and re-suspended in 15 μl loading solvent 
(97.05% H2O, 2% acetonitrile, 0.05% formic acid).
Peptides (8 μl) were loaded onto a Dionex Ultimate 3000 nano-flow ultra-high-pressure liquid chromatog-
raphy system (Thermo Scientific) with a 75 µm × 2 cm C18 trap column (Thermo Scientific) and separated on a 
75 µm × 25 cm C18 reverse-phase analytical column (Thermo Scientific) at 40 °C. Elution was carried out with 
mobile phase B (80% acetonitrile with 0.1% formic acid) gradient (2 to 35% B) over 310 min at a flow rate of 
0.3 μl/min. Peptides were measured using a Q Exactive Orbitrap mass spectrometer (Thermo Scientific) cou-
pled to the chromatography system via a nano-electrospray ion source (Thermo Scientific). The MS1 settings 
were: Resolution, 70000; Automatic gain control (AGC) target, 3e6; maximum injection time, 120 ms; scan range, 
380–2000 m/z; while the MS2 settings were: Resolution, 35000; AGC target, 5e4; maximum injection time, 120 ms; 
isolation window, 2.0 m/z. The top 15 most intense ions were selected for MS2 and fragmented with higher-energy 
collision fragmentation using normalized collision energy of 28 V and these ions were subsequently excluded for 
the next 30 s.
Mass spectrometry protein identification and quantitation. Mass spectrometer raw files were ana-
lysed by MaxQuant software version 1.6.0.168 and peptide lists were searched against the human Uniprot FASTA 
database (Downloaded February 2014) using the Andromeda search engine69. Cysteine carbamidomethylation 
and TMT-10plex labelled N-terminus and lysine were set as a fixed modification and N-terminal acetylation and 
methionine oxidations as variable modifications. The false discovery rate (FDR70) was set to 0.01 for both proteins 
and peptides with a minimum length of seven amino acids and was determined by searching a reverse database. 
Enzyme specificity was set as C-terminal to arginine and lysine with trypsin as the protease. A maximum of two 
missed cleavages were allowed in the database search. Peptide identification was performed with an allowed ini-
tial precursor mass deviation of up to 7 parts per million (ppm) and an allowed fragment mass deviation of up to 
20 ppm. Other parameters were used as default settings for Orbitrap-type data. The 10-plex corrected reporter 
ion intensity matrix was extracted from the MaxQuant proteingroups output file and batch corrected using the 
pooled sample channels. Protein groups are clusters of proteins or protein isoforms with high sequence similarity 
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cannot be unambiguously identified by unique peptides (but have only shared peptides) are grouped in one 
protein group and quantified together. Potential contaminants, protein hits from decoy database, and proteins 
initially depleted but subsequently detected were excluded before exporting the proteingroup matrix file into the 
analytical and manipulation environment.
Total protein, sCD14, Leptin, and cytokines measurement in plasma. Total plasma protein con-
centration was determined using the bicinchoninic acid assay (BCA assay; Thermo Scientific) according to man-
ufacturer’s instructions using diluted plasma samples (1:50). Human Soluble CD14 (sCD14) and leptin ELISAs 
(Quantikine R&D systems) were conducted according to manufacturer’s protocols and plates were read on a 
synergy 4 (BioTek) plate reader. Plasma samples were diluted at 1:200 for sCD14 and 1:10 for leptin. Samples and 
standards were assayed in duplicate to obtain an average of the absorbance and the concentration of the samples 
was calculated based on the calibration curves and dilution factor. Cytokine and chemokines (n = 29) concentra-
tion in plasma were determined by using a human cytokine magnetic bead assay (EMD Millipore) on the Magpix 
with Xponent software (version 4.2; Luminex Corp) and acquired Median Fluorescent Intensity data analysed 
using the Milliplex analyst software (version 3.5.5.0 standard). Table S2 lists all cytokines assessed.
Bioinformatics and statistical analysis. R statistical software version 3.4.271 and Stata software version 
13.1 (StataCorp. LLC USA) were used for analysis. For proteomics, columns containing the protein identifiers 
(IDs), protein names, gene names, and corrected reporter ion intensity in the protein group matrix file from 
MaxQuant was batch corrected using control reporter ion intensity channels and log normalised. Except for 
proteomic measurements, data is presented as medians with interquartile ranges (IQRs), means ± the standard 
deviations (SD), and percentage.
The Gene ontology (GO) enriched biological processes (BP) of differentially expressed proteins (DEP) and 
cytokines was determined using The Database for Annotation, Visualization and Integrated Discovery (DAVID) 
v6.8 Bioinformatics Resource66. Homo sapiens was used as “background” for enrichment calculation. Pearson’s 
pairwise correlation analysis between variables was conducted in Stata.
Differential protein expression analysis for proteomics data was initially carried out using the edgeR toolbox 
as implemented in R while Two-sample Wilcoxon rank-sum (Mann-Whitney) test was used for the luminex data. 
The Benjamini and Hochberg (BH) FDR method was used to correct for multiple testing of proteins70. To assess 
variation and determine case-control group separation, exploratory unsupervised clustering using principal com-
ponent analysis (PCA) and k-means clustering was used.
To examine differences in characteristics between cases and controls, 2-sample t test and Wilcoxon rank-sum 
test (of non-normally distributed variables) were used. Chi-square or Fisher’s exact tests were used to assess dif-
ferences in proportions. Length-for-age was calculated using the WHO 2006 children growth standard reference. 
MUAC and length-for-age are presented as z scores ± SD.
To investigate their association with death, proteins with FDR-corrected significant differences between cases 
and controls were taken into a multivariable Cox regression model in order to adjust for potential confounders 
(age, sex, MUAC, the presence of oedema, site, and randomised arm). We hypothesised that proteins measured 
at baseline would have their strongest effect on early deaths, in which case covariates may not have met the pro-
portional hazards assumption for Cox regression. This was confirmed to be true for some protein covariates by 
examining Schoenfeld residuals. We therefore included a term for an interaction between each protein covariate 
and time. Age was also found to have an interaction with time and a term for this was also included in each model 
(illustrated in Fig. S1). The final models yielded two hazards ratios (HR), one for the effect at time = 0 and one for 
the change in HR per unit time72.
ethics approval and consent to participate. The study had been approved by Kenya Medical Research 
Institute (KEMRI) Scientific and Ethics Review Committee (SERU: 2782) and informed consent sought from 
mothers or guardians of study participants.
Data Availability
The mass spectrometry raw files generated and analysed in the current study have been deposited to the Pro-
teomeXchange Consortium73 (PXD010668), via the MassIVE partner repository (MSV000082745), under the 
following title: Biomarkers of post-stabilization mortality in severe acute malnutrition.
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